Bridgeway Capital Management, LLC

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
1,172
Total Value
3970974010
Accession Number
0001085146-25-003239
Form Type
13F-HR
Manager Name
Bridgeway Capital Management, LLC
Data Enrichment
97% identified
1,140 identified32 unidentified

Holdings

1,172 positions
Manager:
Search and click to pin securities to the top
Armata Pharmaceuticals, Inc.
Shares:
44682(-35.9%)
Value:
$65.2M(-49.4%)
Cabaletta Bio, Inc.
Shares:
45675(-47.9%)
Value:
$63.3M(-68.2%)
Alto Neuroscience, Inc.
Shares:
29100
Value:
$62.9M
008064107
Shares:
25000(-58.3%)
Value:
$62.8M(-60.5%)
UNITED STATES ANTIMONY CORP
Shares:
27800
Value:
$61.2M
Rallybio Corp
Shares:
91600(+0.0%)
Value:
$60.0M(-31.8%)
Hyliion Holdings Corp.
Shares:
42500(+0.0%)
Value:
$59.5M(-46.4%)
Drilling Tools International Corp
Shares:
25000
Value:
$59.3M
MEI Pharma, Inc.
Shares:
26869(+0.0%)
Value:
$58.8M(-11.0%)
US ENERGY CORP
Shares:
48848(+0.0%)
Value:
$58.6M(-26.4%)
Rani Therapeutics Holdings, Inc.
Shares:
46500(-17.7%)
Value:
$58.6M(-24.3%)
Century Therapeutics, Inc.
Shares:
120500(-51.7%)
Value:
$57.4M(-77.3%)
Gain Therapeutics, Inc.
Shares:
30004(+0.0%)
Value:
$57.3M(-11.6%)
Nine Energy Service, Inc.
Shares:
50000(-46.1%)
Value:
$56.5M(-45.6%)
MAIA Biotechnology, Inc.
Shares:
36000(-21.2%)
Value:
$55.1M(-39.1%)
Greenland Technologies Holding Corp.
Shares:
30000
Value:
$52.5M
Unity Biotechnology, Inc.
Shares:
50000(+0.0%)
Value:
$52.0M(+6.5%)
NANOVIRICIDES, INC.
Shares:
44039(+0.0%)
Value:
$51.5M(-18.2%)
Xilio Therapeutics, Inc.
Shares:
71081(+0.0%)
Value:
$51.5M(-24.1%)
HARVARD BIOSCIENCE INC
Shares:
89517(-30.8%)
Value:
$50.7M(-81.4%)